KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Jazz Pharmaceuticals (JAZZ) Net Margin (2016 - 2025)

Historic Net Margin for Jazz Pharmaceuticals (JAZZ) over the last 16 years, with Q3 2025 value amounting to 22.33%.

  • Jazz Pharmaceuticals' Net Margin rose 19200.0% to 22.33% in Q3 2025 from the same period last year, while for Sep 2025 it was 8.46%, marking a year-over-year decrease of 201100.0%. This contributed to the annual value of 13.81% for FY2024, which is 29100.0% up from last year.
  • Latest data reveals that Jazz Pharmaceuticals reported Net Margin of 22.33% as of Q3 2025, which was up 19200.0% from 68.7% recorded in Q2 2025.
  • Over the past 5 years, Jazz Pharmaceuticals' Net Margin peaked at 22.33% during Q3 2025, and registered a low of 68.7% during Q2 2025.
  • Over the past 5 years, Jazz Pharmaceuticals' median Net Margin value was 5.93% (recorded in 2023), while the average stood at 0.58%.
  • Per our database at Business Quant, Jazz Pharmaceuticals' Net Margin soared by 524900bps in 2022 and then plummeted by -851700bps in 2025.
  • Quarter analysis of 5 years shows Jazz Pharmaceuticals' Net Margin stood at 3.61% in 2021, then tumbled by -584bps to 24.68% in 2022, then soared by 138bps to 9.35% in 2023, then skyrocketed by 88bps to 17.56% in 2024, then rose by 27bps to 22.33% in 2025.
  • Its last three reported values are 22.33% in Q3 2025, 68.7% for Q2 2025, and 17.56% during Q4 2024.